Dr. Marty Makary pointed out the Biden administration's decision to skip key committee meetings when authorizing vaccines, in response to a top Democrat's question.
CNET on MSN22h
How the 3 New COVID Vaccines Change the Way You PayNow that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more.
Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...
The Patent Trial and Appeal Board agreed with Pfizer and its German partner that Moderna's patents were invalid based on "prior art" that disclosed the inventions before Moderna patented them. The ...
The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.
It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...
11h
Axios on MSNStates push fight against mRNA vaccinesThe mRNA vaccines that helped to end the COVID pandemic — and stoked a considerable amount of vaccine skepticism and ...
Dr. Jay Bhattacharya told Sen. Josh Hawley that he supports developing alternatives for vaccines and therapeutics that use aborted cell lines.
23h
Clinical Trials Arena on MSNFDA puts clinical hold on BioNTech’s malaria vaccine trialThe FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.
Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results